Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 32, 2020 - Issue 6
303
Views
8
CrossRef citations to date
0
Altmetric
Research Articles

Absence of mesothelioma risk maintained in an expanded international cohort of cosmetic talc miners and millers

ORCID Icon & ORCID Icon
Pages 257-264 | Received 03 Jan 2020, Accepted 05 Jun 2020, Published online: 22 Jun 2020

References

  • Addison J, Langer AM. 2000. Draft comments on the NTP draft report on carcinogens background document for talc asbestiform and non-asbestiform. Yorkshire: John Addison Consultancy.
  • Addison J, McConnell EE. 2008. A review of carcinogenicity studies of asbestos and non-asbestos tremolite and other amphiboles. Regul Toxicol Pharmacol. 52(1 Suppl):S187–S199.
  • Anderson EL, Sheehan PJ, Kalmes RM, Griffin JR. 2017. Assessment of health risk from historical use of cosmetic talcum powder. Risk Anal. 37(5):918–929.
  • [ATS] American Thoracic Society. 1990. Health effects of tremolite. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, June 1990. Am Rev Respirat Dis. 142(6 Pt 1):1453–1458.
  • [ATSDR] Agency for Toxic Substances and Disease Registry 2001. Toxicological profile for asbestos. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry.
  • Aylott RI, Byrne GA, Middleton JD, Roberts ME. 1979. Normal use levels of respirable cosmetic talc: Preliminary study. Int J Cosmet Sci. 1(3):177–186.
  • Boffetta P, Malvezzi M, Pira E, Negri E, La Vecchia C. 2018. International analysis of age-specific mortality rates from mesothelioma on the basis of the International Classification of Diseases, 10th revision. J Glob Oncol. 4:1–15.
  • Boundy MG, Gold K, Martin K, Jr. Burgess WA, Dement JA. 1979. Occupational exposures to non-asbestiform talc in Vermont. In: Lemen R, Dement JM, editors. Dusts and disease. Park Forest South, IL: Pathotox Publisher Inc.; p. 356–378.
  • Breslow NE, Day NE. 1987. Statistical methods in cancer research. Volume II–The design and analysis of cohort studies. IARC Sci Publ. (82):1–406. https://pubmed.ncbi.nlm.nih.gov/3329634/
  • Brown R. 1985. Memo from QRAC (Quantitative Risk Assessment Committee) to W. Gary Flamm, Ph.D. (Director, Office of Toxicological Sciences – Food and Drug Administration), RE: Asbestos in Talc. Dated June 6, 1985.
  • Burns AM, Barlow CA, Banducci AM, Unice KM, Sahmel J. 2019. Potential airborne asbestos exposure and risk associated with the historical use of cosmetic talcum powder products. Risk Anal. 39(10):2272–2294.
  • Caneer WT. 1973. Internal Memo from W. T. Caneer (Colorado School of Mines Research Institute) to W. H. Ashton (Colorado School of Mines Research Institute), RE: Meeting with Bowling Green State University Geological Staff. Dated June 8, 1973.
  • Coggiola M, Bosio D, Pira E, Piolatto PG, La Vecchia C, Negri E, Michelazzi M, Bacaloni A. 2003. An update of a mortality study of talc miners and millers in Italy. Am J Ind Med. 44(1):63–69.
  • [CPSC] Consumer Product Safety Commission 1988. Briefing package of the CPSC office of the secretary on a petition to ban play sand with non-asbestiform tremolite. Washington, D.C.: U.S. Product Safety Commission.
  • Cralley LJ, Key MM, Groth DH, Lainhart WS, Ligo RM. 1968. Fibrous and mineral content of cosmetic talcum products. Am Ind Hyg Assoc J. 29(4):350–354.
  • Dement JM, Shuler PJ, Zumwalde RD. 1972. Preliminary Report: Fiber Exposure During Use of Baby Powders. Cincinnati, OH: Environmental Investigations Branch, Division of Field Studies and Clinical Investigations, National Institute for Occupational Safety and Health.
  • Emory TS, Maddox JC, Kradin RL. 2020. Malignant mesothelioma following repeated exposures to cosmetic talc: a case series of 75 patients. Am J Ind Med. 63(6):484–489.
  • Finley BL, Benson SM, Marsh GM. 2017. Cosmetic talc as a risk factor for pleural mesothelioma: A weight of evidence evaluation of the epidemiology. Inhal Tox. 29(4):179–185.
  • Finley BL, Pierce JS, Phelka AD, Adams RE, Paustenbach DJ, Thuett KA, Barlow CA. 2012. Evaluation of tremolite asbestos exposures associated with the use of commercial products. Crit Rev Toxicol. 42(2):119–146.
  • Fordyce TA, Leonhard MJ, Mowat FS, Moolgavkar SH. 2019. A 37-year update on mortality patterns in an expanded cohort of Vermont talc miners and millers. J Occup Env Med. 61(11):916–923.
  • Fordyce TA, Leonhard MJ, Mowat FS, Moolgavkar SH. 2020. Letter to the Editor: Egilman et al.’s misrepresentation of the Fordyce et al. (2019) Vermont talc miners and millers cohort study update. J Occup Env Med. 62(1):e19–e21.
  • Gaffney SH, Grespin M, Garnick L, Drechsel DA, Hazan R, Paustenbach DJ, Simmons BD. 2017. Anthophyllite asbestos: state of the science review. J Appl Toxicol. 37(1):38–49.
  • Gamble JF, Gibbs GW. 2008. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments. Regul Toxicol Pharmacol. 52(1 Suppl):S154–S186.
  • Gordon RE, Fitzgerald S, Millette J. 2014. Asbestos in commercial cosmetic talcum powder as a cause of mesothelioma in women. Int J Occup Environ Health. 20(4):318–332.
  • Henley SJ, Larson TC, Wu M, Antao VC, Lewis M, Pinheiro GA, Eheman C. 2013. Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003-2008. Int J Occup Environ Health. 19(1):1–10.
  • Hildick-Smith GY. 1976. The biology of talc. Br J Ind Med. 33(4):217–229.
  • [IARC] International Agency for Research on Cancer 2010. IARC monographs on the evaluation of carcinogenic risks to humans Vol. 93. Carbon Black, Titanium Dioxide, and Talc. Lyon, France: International Agency for Research on Cancer.
  • Krause JB. 1977. Mineralogical characterization of cosmetic talc products. J Toxicol Environ Health. 2(5):1223–1226.
  • Lamm SH, Starr JA. 1990. Similarities in lung cancer and respiratory disease mortality of Vermont and New York State talc workers. In: NIOSH, editor. Proceedings of the VIIth International Pneumoconioses Conference, August 23-26, 1988, Pittsburgh, Pennsylvania Publication No 90–108, 1990 Nov; (Part II). Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health; p. 1576–1581.
  • Lewin SZ. 1972. Memo from Seymour Z. Lewin (Professor of Chemistry, New York University) to Dr. Alfred Weissler (Acting Director, Division of Colors and Cosmetics Technology, Office of Product Technology, Food and Drug Administration), RE: Lewin’s Final Analytical Results on the Mineral Compositions of 102 Examples of Standard, Commercial Products Containing Talc (With Attachment). Dated August 3, 1972.
  • Lightfoot J, Kingston GA, Pooley FD. 1972. An examination of italian mine samples and Relevant powders. Cardiff, (UK): Cardiff University.
  • Marsh GM, Ierardi AM. 2020. Confidence interval function analysis to evaluate the risk of mesothelioma among an expanded international cohort of cosmetic talc miners and millers. Regul Toxicol Pharmacol. doi:10.1016/j.yrtph.2020.104696.
  • Marsh GM, Ierardi AM, Benson SM, Finley BL. 2019. Occupational exposures to cosmetic talc and risk of mesothelioma: An updated pooled cohort and statistical power analysis with consideration of latency period. Inhal Tox. 31(6):213–223.
  • Mirabelli D. 2018. Letter on: “Mortality of Talc Miners and Millers From Val Chisone, Northern Italy. J Occup Env Med. 60(1):e72.
  • Moline J, Bevilacqua K, Alexandri M, Gordon RE. 2020. Mesothelioma associated with the use of cosmetic talc. J Occup Env Med. 62(1):11–17.
  • Moolgavkar SH, Chang ET, Mezei G, Mowat FS. 2017. Chapter 3, Epidemiology of mesothelioma. In: Testa JR, editor. Asbestos and mesothelioma current cancer research. Cham, Switzerland: Springer; p. 43–72.
  • Moolgavkar SH, Meza R, Turim J. 2009. Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973–2005. Cancer Causes Control. 20(6):935–944.
  • Moon MC, Park JD, Choi BS, Park SY, Kim DW, Chung YH, Hisanaga N, Yu IJ. 2011. Risk assessment of baby powder exposure through inhalation. Toxicol Res. 27(3):137–141.
  • Mossman BT. 2008. Assessment of the pathogenic potential of asbestiform vs. nonasbestiform particulates (cleavage fragments) in in vitro (cell or organ culture) models and bioassays. Regul Toxicol Pharmacol. 52(1 Suppl):S200–S203.
  • Mossman BT. 2018. Mechanistic in vitro studies: what they have told us about carcinogenic properties of elongated mineral particles (EMPs). Tox Appl Pharm. 361:62–67.
  • [OSHA] Occupational Safety and Health Administration. 1992. 29 CFR Parts 1910 and 1926: occupational exposure to asbestos, tremolite, anthophyllite and actinolite; final rule. Fed Reg. 57(110):24310–24331.
  • Parkes WR. 1982. Occupational lung disorders. 2nd ed. Boston: Butterworths.
  • Pierce JS, Riordan AS, Miller EW, Gaffney SH, Hollins DM. 2017. Evaluation of the presence of asbestos in cosmetic talcum products. Inhal Toxicol. 29(10):443–456.
  • Pira E, Coggiola M, Ciocan C, Romano C, La Vecchia C, Pelucchi C, Boffetta P. 2017. Mortality of talc miners and millers from Val Chisone, Northern Italy: an updated cohort study. J Occup Environ Med. 59(7):659–664.
  • Pira E, Coggiola M, Ciocan C, Romano C, La Vecchia C, Pelucchi C, Boffetta P. 2018. Response to letter to the editor on the mortality of talc miners and millers from Val Chisone, Northern Italy. J Occup Env Med. 60(1):e73.
  • Pooley FD. [date unknown]. Report of the examination of rock sampels from the vermont mine. UK: Department of Mineral Exploitation, Cardiff University.
  • Pooley FD. 1976. Letter from Dr. F.D. Pooley, Department of Mineral Exploitation, University College, Cardiff, to Dr. R.E. Shapiro, Ph.D., Epidemiology Unit, HFF-108, Department of Health, Education & Welfare, Public Health Service, Food and Drug Administration, Washington, D.C. Dated March 9, 1976. Cardiff: University College.
  • Rasmussen PE, Levesque C, Niu J, Gardner HD, Nilsson G, Macey K. 2019. Characterization of airborne particles emitted during application of cosmetic talc products. IJERPH. 16(20):3830.
  • Roggli VL, Carney JM, Sporn TA, Pavlisko EN. 2020. Talc and mesothelioma: mineral fiber analysis of 65 cases with clinicopathological correlation. Ultrastruct Pathol. 44(2):211–218.
  • Rohl AN, Langer AM. 1974. Identification and quantitation of asbestos in talc. Environ Health Perspect. 9:95–109.
  • Rohl AN, Langer AM, Selikoff IJ, Tordini A, Klimentidis R, Bowes DR, Skinner DL. 1976. Consumer talcums and powders: mineral and chemical characterization. J Toxicol Environ Health. 2(2):255–284.
  • Rohl AN, Langer AM. 1979. Fibrous mineral content of consumer talc-containing products. In: Lemen R, Dement JM, editors. Dusts and disease. Park Forest South (IL): Pathotox Publishers; p. 393–403.
  • Rossner A, Williams PRD, Mellas-Hulett E, Arifur Rahman M. 2020. Analysis of historical worker exposures to respirable dust from talc mining and milling operations in Vermont. Ann Work Expo Health. 64(4):416–429.
  • Rubino GF, Scansetti G, Piolatto G. 1979. Mortality and morbidity among talc miners and millers in Italy. In: Lemen R, Dement JM, editors. Dusts and disease: proceedings of the conference on occupational exposures to fibrous and particulate dust and their extension into the environment. Park Forest South (IL): Pathotox Publishers; p. 357–363.
  • Rubino GF, Scansetti G, Piolatto G, Romano CA. 1976. Mortality study of talc miners and millers. J Occup Med. 18:186–193.
  • Russell RS, Merz RD, Sherman WT, Sivertson JN. 1979. The determination of respirable particles in talcum powder. Food Cosmet Toxicol. 17(2):117–122.
  • Selevan SG, Dement JM, Wagoner JK, Froines JR. 1979. Mortality patterns among miners and millers of non-asbestiform talc: preliminary report. J Environ Pathol Toxicol. 2(5):273–284.
  • Snider DW, Pfeiffer DE, Mancuso JJ. 1972. Asbestosform impurities in commerical talcum powders. Compass of Sigma Gamma Epsilon. 49:65–67.
  • Swanson JW. 1986. Memo from J.W. Swanson (Acting Associate Commissioner for Regulatory Affairs – U.S. Food and Drug Administration) to Mr. Phillippe Douillet, RE: Docket Number 1982P-404, Denying a November 8, 1983, Petition Requesting that Cosmetic Talc be Labeled with an Asbestos Warning Statement (Includes Enclosures/Talc Documents). Dated July 11, 1986.
  • [USEPA] U.S. Environmental Protection Agency 1992. Health assessment document for talc. EPA-600/8-91/217. Washington, (DC).: Office of Reseach and Development, U.S. Environmental Protection Agency.
  • [USFDA] U.S. Food and Drug Administration 1971. FDA Meeting Minutes- Asbestos in Cosmetic Talc. August 3, 1971 – Washington, (DC).
  • Vu VT. 1993. Chapter 19, Regulatory approaches to reduce human health risks associated with exposures to mineral fibers. In: Guthrie Jr. GD, Mossman BT, editors. Health effects of mineral dusts Vol 28. Washington, D.C.: Mineralogical Society of America; p. 545–554.
  • Wegman DH, Peters JM, Boundy MG, Smith TJ. 1982. Evaluation of respiratory effects in miners and millers exposed to talc free of asbestos and silica. Br J Ind Med. 39(3):233–238.
  • Weissler A. 1973. Internal Memo from Alfred Weissler Ph.D. (Acting Director- Division of Color Technology, U.S. Food and Drug Administration) to Dr. Robert M. Schaffner (Director – Office of Technology, U.S. Food and Drug Administration), RE: Summary and Comments on Prof. Lewin’s Analytical Results for Asbestos in Talc (Enclosures Included – Final Report: X-Ray Powder Diffraction Analyses of Commerical Cosmetic Powders). Dated July 31, 1973.
  • Wergeland E, Andersen A, Baerheim A. 1990. Morbidity and mortality in talc-exposed workers. Am J Ind Med. 17(4):505–513.
  • Wergeland E, Gjertsen F, Vos L, Grimsrud TK. 2017. Cause-specific mortality and cancer morbidity in 390 male workers exposed to high purity talc, a six-decade follow-up. Am J Ind Med. 60(9):821–830.
  • Wild P, Leodolter K, Refregier M, Schmidt H, Zidek T, Haidinger G. 2002. A cohort mortality and nested case-control study of French and Austrian talc workers. Occup Environ Med. 59(2):98–105.
  • Williams C, Dell L, Adams R, Rose T, Van Orden D. 2013. State-of-the-science assessment of non-asbestos amphibole exposure: is there a cancer risk? Environ Geochem Health. 35(3):357–377.
  • Zazenski R, Ashton WH, Briggs D, Chudkowski M, Kelse JW, MacEachern L, McCarthy EF, Nordhauser MA, Roddy MT, Teetsel NM. 1995. Talc: occurrence, characterization, and consumer applications. Regul Toxicol Pharmacol. 21(2):218–229.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.